CY1113885T1 - Μια ιατρικη κρεμα φουσιδικου οξεος που παρασκευαζεται με την χρηση φουσιδικου νατριου και ενσωματωση ενος βιοπολυμερους και μια μεθοδος για την παρασκευη της - Google Patents
Μια ιατρικη κρεμα φουσιδικου οξεος που παρασκευαζεται με την χρηση φουσιδικου νατριου και ενσωματωση ενος βιοπολυμερους και μια μεθοδος για την παρασκευη τηςInfo
- Publication number
- CY1113885T1 CY1113885T1 CY20131100257T CY131100257T CY1113885T1 CY 1113885 T1 CY1113885 T1 CY 1113885T1 CY 20131100257 T CY20131100257 T CY 20131100257T CY 131100257 T CY131100257 T CY 131100257T CY 1113885 T1 CY1113885 T1 CY 1113885T1
- Authority
- CY
- Cyprus
- Prior art keywords
- cream
- skin
- acid
- biopolymer
- sodium
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 239000002253 acid Substances 0.000 title abstract 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 title abstract 2
- 229920001222 biopolymer Polymers 0.000 title abstract 2
- 229910052708 sodium Inorganic materials 0.000 title abstract 2
- 239000011734 sodium Substances 0.000 title abstract 2
- 239000006071 cream Substances 0.000 abstract 7
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 206010052428 Wound Diseases 0.000 abstract 2
- 208000027418 Wounds and injury Diseases 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 229920001661 Chitosan Polymers 0.000 abstract 1
- IECPWNUMDGFDKC-UHFFFAOYSA-N Fusicsaeure Natural products C12C(O)CC3C(=C(CCC=C(C)C)C(O)=O)C(OC(C)=O)CC3(C)C1(C)CCC1C2(C)CCC(O)C1C IECPWNUMDGFDKC-UHFFFAOYSA-N 0.000 abstract 1
- 241000682907 Fusidium Species 0.000 abstract 1
- 208000003251 Pruritus Diseases 0.000 abstract 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- IECPWNUMDGFDKC-MZJAQBGESA-N fusidic acid Chemical compound O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C(O)=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-N 0.000 abstract 1
- 229960004675 fusidic acid Drugs 0.000 abstract 1
- 238000011065 in-situ storage Methods 0.000 abstract 1
- 239000011261 inert gas Substances 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 230000003716 rejuvenation Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Η παρούσα εφεύρεση απευθύνεται σε μία ιατρική σύνθεση για την θεραπεία βακτηριακών επιδερμικών μολύνσεων και σχετικών τραυμάτων, καθώς επίσης και άλλων επιδερμικών τραυμάτων που περιλαμβάνουν εκείνα που προκαλούνται από εγκαύματα. Η κρέμα προκαλεί επίσης αναζωογόνωση του δέρματος μέσω μιας διαδικασίας επαναεπιθηλίωσης. Η κρέμα περιλαμβάνει α) ένα βιοπολυμερές υπό την μορφή Χιτοζάνης, β) ένα Δραστικό Φαρμακευτικό Συστατικό (API) υπό την μορφή φουσιδικού, γ) μία βάση κρέμας και δ) νερό. Η εφεύρεση επίσης αποκαλύπτει μία μέθοδο για την παρασκευή της ιατρικής κρέμας στην οποία το Φουσιδικό οξύ το οποίον σχηματίζεται επί τόπου (in situ) από το Φουσιδικό νάτριο ως ακατέργαστη αρχική ουσία, με μετατροπή αυτού σε Φουσιδικό οξύ κάτω από ελεύθερο οξυγόνου περιβάλλον που δημιουργείται με την χρήση αδρανούς αερίου, κατά προτίμηση αζώτου. Η κρέμα που παράγεται με την μέθοδο της παρούσας εφεύρεσης έχει μεγαλύτερη σταθερότητα στο ράφι και πιο μικρό μέγεθος σωματιδίων του API από τις συνηθισμένες κρέμες που περιέχουν φουσιδικό οξύ και βρέθηκε να είναι εκπληκτικά ανώτερη για χρήση έναντι μολύνσεων του δέρματος με αλλεργία και κνησμό, και τραύματα στο ανθρώπινο δέρμα από τις εναλλακτικές κρέμες που επί του παρόντος είναι διαθέσιμες.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN960MU2009 | 2009-04-13 | ||
| EP10718707A EP2419087B1 (en) | 2009-04-13 | 2010-04-12 | A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1113885T1 true CY1113885T1 (el) | 2016-07-27 |
Family
ID=42558569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20131100257T CY1113885T1 (el) | 2009-04-13 | 2013-03-27 | Μια ιατρικη κρεμα φουσιδικου οξεος που παρασκευαζεται με την χρηση φουσιδικου νατριου και ενσωματωση ενος βιοπολυμερους και μια μεθοδος για την παρασκευη της |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8895542B2 (el) |
| EP (1) | EP2419087B1 (el) |
| JP (1) | JP5205549B2 (el) |
| KR (1) | KR101642537B1 (el) |
| CN (1) | CN102159191B (el) |
| BR (1) | BRPI1006729B1 (el) |
| CA (1) | CA2795611C (el) |
| CY (1) | CY1113885T1 (el) |
| DK (1) | DK2419087T3 (el) |
| ES (1) | ES2404156T3 (el) |
| HR (1) | HRP20130149T1 (el) |
| IL (1) | IL215641A (el) |
| MX (1) | MX2011010784A (el) |
| PL (1) | PL2419087T3 (el) |
| PT (1) | PT2419087E (el) |
| RU (1) | RU2537023C2 (el) |
| SI (1) | SI2419087T1 (el) |
| SM (1) | SMT201300059B (el) |
| WO (1) | WO2010119385A1 (el) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101457789B1 (ko) | 2013-02-13 | 2014-11-03 | 동아제약 주식회사 | 상처 치료용 필름형성 약제학적 조성물 및 그의 제조방법 |
| WO2014144423A2 (en) * | 2013-03-15 | 2014-09-18 | Techulon Inc. | Antisense molecules for treatment of staphylococcus aureus infection |
| WO2017091167A1 (en) | 2015-11-28 | 2017-06-01 | Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş. | Topical pharmaceutical composition comprising fusidic acid, isoconazole, dexpanthenol and hydrocortisone |
| MX2019014772A (es) | 2017-06-12 | 2020-02-07 | Lakewood Amedex Inc | Formulaciones en gel de bisfosfocinas y usos de estas. |
| CN107224426A (zh) * | 2017-07-08 | 2017-10-03 | 天津双硕医药科技有限公司 | 一种含有夫西地酸的外用乳膏组合物 |
| CN111012747B (zh) * | 2018-10-10 | 2022-11-25 | 四川海思科制药有限公司 | 一种注射用夫西地酸钠药物组合物及其制备方法 |
| CN114432250B (zh) * | 2022-02-22 | 2022-10-04 | 深圳市泰力生物医药有限公司 | 一种非晶态夫西地酸的稳定方法 |
| WO2025099639A1 (en) * | 2023-11-08 | 2025-05-15 | Sulur Vishagan Vanangamudi | Compositions and methods for treating skin disorders |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8500310D0 (en) * | 1985-01-07 | 1985-02-13 | Leo Pharm Prod Ltd | Pharmaceutical preparation |
| SU1380751A2 (ru) * | 1986-03-12 | 1988-03-15 | Всесоюзный научно-исследовательский институт антибиотиков | Средство дл лечени гнойно-воспалительных заболеваний кожи и м гких тканей |
| DK603988D0 (da) * | 1988-10-28 | 1988-10-28 | Klaus Bendtzen | Farmaceutisk praeparat |
| TW460296B (en) * | 1994-09-01 | 2001-10-21 | Janssen Pharmaceutica Nv | Topical ketoconazole emulsion compositions without sodium sulfite |
| PT1032378E (pt) * | 1997-11-25 | 2002-07-31 | Yamanouchi Europ Bv | Utilizacao de uma mistura de um iol e um acido alfa-hidroxi para o tratamento de doencas da pele hiperqueratoticas |
| US20070265352A1 (en) * | 2002-02-19 | 2007-11-15 | Joachim Roeding | Synergistic mixtures of at least one 1,2 alkanediol such as 1,2-hexanediol and 1,2-octanediol with a further compound having antimicrobial properties |
| ES2204331B1 (es) * | 2002-10-09 | 2005-03-01 | Ercros Industrial, S.A. | Procedimiento para la obtencion de acido fusidico a partir de un caldo de fermentacion. |
| US20080206161A1 (en) * | 2002-10-25 | 2008-08-28 | Dov Tamarkin | Quiescent foamable compositions, steroids, kits and uses thereof |
| RU2240781C1 (ru) * | 2003-06-05 | 2004-11-27 | Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии | Способ лечения воспалительных процессов вульвы и влагалища |
| CA2559629A1 (en) * | 2004-03-16 | 2005-09-29 | Glaxo Group Limited | Pyrazolo[3,4-b]pyridine compound, and its use as a pde4 inhibitor |
| BRPI0707367A2 (pt) * | 2006-02-02 | 2011-05-03 | Leo Pharma As | composição farmacêutica, uso de uma composição, e, método de prevenir ou tratar uma doença dérmica ou condição da pele ou mucosa |
| US9132071B2 (en) | 2006-07-28 | 2015-09-15 | Santen Sas | Compositions containing quaternary ammonium compounds |
| US20080182819A1 (en) * | 2007-01-29 | 2008-07-31 | Act Iii Licensing, Llc | Chitosan compositions and methods for using chitosan compositions in the treatment of health disorders |
| RU2536252C2 (ru) * | 2008-12-19 | 2014-12-20 | Сулур Субраманиам ВАНАНГАМУДИ | Новый дерматологический крем, изготовленный с использованием фусидата натрия |
| EP2403480B1 (en) * | 2009-02-18 | 2013-04-03 | Sulur Subramaniam Vanangamudi | A process to make fusidic acid cream |
-
2010
- 2010-04-12 KR KR1020117026914A patent/KR101642537B1/ko active Active
- 2010-04-12 PL PL10718707T patent/PL2419087T3/pl unknown
- 2010-04-12 PT PT107187072T patent/PT2419087E/pt unknown
- 2010-04-12 US US13/263,846 patent/US8895542B2/en active Active
- 2010-04-12 CA CA2795611A patent/CA2795611C/en active Active
- 2010-04-12 HR HRP20130149AT patent/HRP20130149T1/hr unknown
- 2010-04-12 EP EP10718707A patent/EP2419087B1/en active Active
- 2010-04-12 CN CN201080002688.7A patent/CN102159191B/zh active Active
- 2010-04-12 MX MX2011010784A patent/MX2011010784A/es active IP Right Grant
- 2010-04-12 WO PCT/IB2010/051552 patent/WO2010119385A1/en not_active Ceased
- 2010-04-12 SI SI201030186T patent/SI2419087T1/sl unknown
- 2010-04-12 DK DK10718707.2T patent/DK2419087T3/da active
- 2010-04-12 RU RU2011146230/15A patent/RU2537023C2/ru active
- 2010-04-12 ES ES10718707T patent/ES2404156T3/es active Active
- 2010-04-12 BR BRPI1006729-9A patent/BRPI1006729B1/pt active IP Right Grant
- 2010-04-12 JP JP2012505268A patent/JP5205549B2/ja active Active
-
2011
- 2011-10-09 IL IL215641A patent/IL215641A/en active IP Right Grant
-
2013
- 2013-03-27 CY CY20131100257T patent/CY1113885T1/el unknown
- 2013-06-05 SM SM201300059T patent/SMT201300059B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20120023653A (ko) | 2012-03-13 |
| RU2537023C2 (ru) | 2014-12-27 |
| WO2010119385A1 (en) | 2010-10-21 |
| CA2795611A1 (en) | 2010-10-21 |
| MX2011010784A (es) | 2012-01-12 |
| US8895542B2 (en) | 2014-11-25 |
| EP2419087A1 (en) | 2012-02-22 |
| EP2419087B1 (en) | 2013-01-23 |
| ES2404156T3 (es) | 2013-05-24 |
| BRPI1006729A2 (pt) | 2020-10-06 |
| PL2419087T3 (pl) | 2013-06-28 |
| BRPI1006729B1 (pt) | 2021-10-05 |
| CA2795611C (en) | 2016-09-20 |
| RU2011146230A (ru) | 2013-05-20 |
| CN102159191A (zh) | 2011-08-17 |
| SI2419087T1 (sl) | 2013-06-28 |
| CN102159191B (zh) | 2014-04-02 |
| IL215641A0 (en) | 2012-01-31 |
| US20120040946A1 (en) | 2012-02-16 |
| SMT201300059B (it) | 2013-07-09 |
| DK2419087T3 (da) | 2013-05-06 |
| JP5205549B2 (ja) | 2013-06-05 |
| PT2419087E (pt) | 2013-04-26 |
| KR101642537B1 (ko) | 2016-07-25 |
| HRP20130149T1 (hr) | 2013-03-31 |
| IL215641A (en) | 2014-09-30 |
| JP2012523451A (ja) | 2012-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1113885T1 (el) | Μια ιατρικη κρεμα φουσιδικου οξεος που παρασκευαζεται με την χρηση φουσιδικου νατριου και ενσωματωση ενος βιοπολυμερους και μια μεθοδος για την παρασκευη της | |
| CY1119616T1 (el) | Συζευγματα ανθρωπινου αντισωματος-φαρμακου κατα του ιστικου παραγοντα | |
| AU2016219653A1 (en) | Crystallization Method and Bioavailability | |
| MY198204A (en) | Cyclic Boronic Acid Ester Derivatives And Therapeutic Uses Thereof | |
| EA201270780A1 (ru) | С-3 модифицированные производные бетулиновой кислоты в качестве ингибиторов созревания вич | |
| EA201291089A1 (ru) | Способ получения фармацевтических препаратов, предназначенных для перорального введения, содержащих один или более активных ингредиентов, и содержащих их композиций | |
| MX367091B (es) | Una composición farmacéutica o cosmética tópica que comprende un extracto de la baya de la fruta milagrosa (synsepalum dulcificum) para usarse en el tratamiento o la prevención de desórdenes en la piel, mebrana mucosa, cabello, articulaciones y uñas. | |
| WO2014140861A3 (en) | Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics | |
| MX389566B (es) | Composicion y dispositivo medico que comprenden acido acetilsalicilico para el tratamiento de infecciones cutaneas por virus de papiloma humano. | |
| EA201691490A1 (ru) | Фармацевтическая композиция, содержащая бринзоламид | |
| CY1115961T1 (el) | Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate) | |
| MX2012013606A (es) | Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas. | |
| PT2459153E (pt) | Composição farmacêutica ou cosmética ou dietética tendo o efeito de favorecer a pigmentação capilar | |
| CY1115734T1 (el) | Συνθεσεις benzenesulfonamide, μεθοδος συνθεσης τους, και χρηση αυτων στην ιατρικη | |
| WO2011058245A8 (fr) | Nouveaux derives de mannopyranoside ayant une activite anticancereuse | |
| UA96794C2 (ru) | Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе | |
| WO2015001163A3 (es) | Nanopartículas lipídicas para la cicatrización de heridas | |
| PH12018500910A1 (en) | Novel method of use and compositions | |
| MX2012013607A (es) | Polisacarido de las semillas de tamarindo para usarse en el tatamiento de enfermedades inflamatorias. | |
| MX2013004394A (es) | Composicion farmaceutica topica de mupirocina. | |
| BR112015004733A2 (pt) | creme de cuidado para pele macia de rápida penetração. | |
| AR086437A1 (es) | Preparado de huevo con propiedades regeneradoras, analgesicas y/o anti-inflamatorias | |
| HK1223852A1 (zh) | 睪丸酮凝膠組合物及相關方法 | |
| CO2022002493A2 (es) | Nanoemulsion de ácido 18p-glicirretínico | |
| MX2017017192A (es) | Biopolimero de quitosano y poloxamero 407 obtenido por irradiacion gamma que exhibe propiedades fisicoqumicas y biologicas para la reparacion de heridas. |